Meritage Portfolio Management’s Halozyme HALO Stock Holding History

Meritage Portfolio Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$5.82M	Sell	86,552 -3,632	-4%	-$244K	0.39%	72
2025 Q3	$6.61M	Sell	90,184 -11,315	-11%	-$752K	0.44%	61
2025 Q2	$5.28M	Sell	101,499 -152	-0.1%	-$8.65K	0.33%	79
2025 Q1	$6.49M	Buy	+101,651	New	+$5.91M	0.43%	67
2023 Q1	–	Sell	-198,041	Closed	-$11.3M	–	324
2022 Q4	$11.3M	Sell	198,041 -6,536	-3%	-$335K	0.88%	18
2022 Q3	$8.09M	Buy	+204,577	New	+$9.04M	0.67%	32

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Meritage Portfolio Management's HALO Position: Q4 2025 in Review

Meritage Portfolio Management reduced its Halozyme (HALO) stake by 4% in Q4 2025, selling an estimated $244K and leaving 86,552 shares worth $5.82M. The position accounts for 0.39% of the portfolio, ranked #72.

Meritage Portfolio Management first reported a position in HALO in Q3 2022 and has held it in 6 quarters since. The position peaked at $11.3M in Q4 2022. 618 funds tracked by Wall St. Rank hold HALO as of Q4 2025.

Meritage Portfolio Management held 86,552 shares of Halozyme worth $5.82M as of Q4 2025.
Meritage Portfolio Management sold 3,632 Halozyme shares in Q4 2025, an estimated $244K.
Halozyme made up 0.39% of Meritage Portfolio Management's portfolio in Q4 2025, its #72 holding.
Meritage Portfolio Management first reported a position in Halozyme in Q3 2022 and has held it in 6 quarters since.
Meritage Portfolio Management's Halozyme position peaked at $11.3M in Q4 2022.
618 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.

Based on Meritage Portfolio Management's 13F filing for Q4 2025, filed 27 Jan 2026.